Scott Delach
Impact in
-
- Cell death mechanisms and regulation
- Heat shock proteins research
Papers in
-
- Cell death mechanisms and regulation 3
- Melanoma and MAPK Pathways 2
- Cancer therapeutics and mechanisms 1
- Oncology 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Daniel E. Johnson (3 shared papers)Andrew Worlock (1 shared paper)Martha Rook (1 shared paper)Richard S. Maser (1 shared paper)Sanjeev Shangary (1 shared paper)Lori A. Emert‐Sedlak (1 shared paper)Q. Ping Dou (1 shared paper)Cheryl L. Fattman (1 shared paper)
- Journals
- Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Molecular Cancer Research (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Scott Delach
11 papers receiving 484 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 85
- Molecular Biology 340
- Oncology 126
- Genetics 35
- Neurology 45
Countries citing papers authored by Scott Delach
This map shows the geographic impact of Scott Delach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Delach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Delach more than expected).
Fields of papers citing papers by Scott Delach
This network shows the impact of papers produced by Scott Delach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Delach. The network helps show where Scott Delach may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Delach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 86 | |
| 2 | 2005 | 84 | |
| 3 | 2001 | 80 | |
| 4 | 2018 | 58 | |
| 5 | Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. | 2000 | 58 |
| 6 | 2016 | 57 | |
| 7 | 2001 | 46 | |
| 8 | 2017 | 18 | |
| 9 | 2019 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2017 | 1 |
About Scott Delach
Scott Delach is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine, having authored 11 papers that have together received 492 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (3 papers), Cell death mechanisms and regulation (3 papers), Melanoma and MAPK Pathways (2 papers), Neuroblastoma Research and Treatments (1 paper), Cancer Genomics and Diagnostics (1 paper), Computational Drug Discovery Methods (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Cancer Research (85 citations), Molecular Biology (340 citations), Oncology (126 citations), Genetics (35 citations) and Neurology (45 citations). Scott Delach has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Daniel E. Johnson, Andrew Worlock, Martha Rook, Richard S. Maser, Sanjeev Shangary, Lori A. Emert‐Sedlak, Q. Ping Dou, Cheryl L. Fattman, Giordano Caponigro and Guoqing Wang. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Molecular Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.